BRPI0812000A2 - Métodos e composições para administração de oxibutinina - Google Patents

Métodos e composições para administração de oxibutinina

Info

Publication number: BRPI0812000A2
Authority: BR; Brazil
Prior art keywords: oxybutinine; administration; compositions; methods; oxybutinine administration
Prior art date: 2007-05-30

Application number

BRPI0812000-5A2A

Other languages

English (en)

Inventor

Michael J Martin

Original Assignee

Microdose Therapeutx Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-30

Filing date

2008-05-30

Publication date

2014-11-18

2008-05-30 Application filed by Microdose Therapeutx Inc filed Critical Microdose Therapeutx Inc

2014-11-18 Publication of BRPI0812000A2 publication Critical patent/BRPI0812000A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

BRPI0812000-5A2A 2007-05-30 2008-05-30 Métodos e composições para administração de oxibutinina BRPI0812000A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US94090707P	2007-05-30	2007-05-30
PCT/US2008/065436 WO2008151092A1 (en)	2007-05-30	2008-05-30	Methods and compositions for administration of oxybutynin

Publications (1)

Publication Number	Publication Date
BRPI0812000A2 true BRPI0812000A2 (pt)	2014-11-18

Family

ID=40088519

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0812000-5A2A BRPI0812000A2 (pt)	2007-05-30	2008-05-30	Métodos e composições para administração de oxibutinina

Country Status (7)

Country	Link
US (1)	US20080299207A1 (pt)
EP (1)	EP2152232A4 (pt)
KR (2)	KR20150011379A (pt)
AU (2)	AU2008259864C1 (pt)
BR (1)	BRPI0812000A2 (pt)
CA (2)	CA2688542C (pt)
WO (1)	WO2008151092A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA05007266A (es) *	2003-01-02	2006-01-17	Femmepharma Holding Co Inc	Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
US9173836B2 (en)	2003-01-02	2015-11-03	FemmeParma Holding Company, Inc.	Pharmaceutical preparations for treatments of diseases and disorders of the breast
EP2104489A2 (en) *	2006-12-26	2009-09-30	FemmePharma Holding Company, Inc.	Topical administration of danazol
US8415390B2 (en) *	2008-05-30	2013-04-09	Microdose Therapeutx, Inc.	Methods and compositions for administration of oxybutynin
US9119777B2 (en) *	2008-05-30	2015-09-01	Microdose Therapeutx, Inc.	Methods and compositions for administration of oxybutynin
US20110003000A1 (en) *	2009-07-06	2011-01-06	Femmepharma Holding Company, Inc.	Transvaginal Delivery of Drugs
EP2772252B1 (en) *	2011-10-26	2020-03-18	Hisamitsu Pharmaceutical Co., Inc.	Oxybutynin-containing transdermal absorption preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5736577A (en) *	1995-01-31	1998-04-07	Sepracor, Inc.	Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
GB8923590D0 (en) *	1989-10-19	1989-12-06	Pfizer Ltd	Antimuscarinic bronchodilators
US5532278A (en) *	1995-01-31	1996-07-02	Sepracor, Inc.	Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5677346A (en) *	1995-01-31	1997-10-14	Sepracor, Inc.	Treating urinary incontinence using (S)-desethyloxybutynin
US6026809A (en) *	1996-01-25	2000-02-22	Microdose Technologies, Inc.	Inhalation device
AU767877B2 (en) *	1999-05-20	2003-11-27	Sepracor, Inc.	Methods for treatment of asthma using S-oxybutynin
US8820316B2 (en) *	2000-02-11	2014-09-02	Respironics Respiratory Drug Delivery (Uk) Ltd	Drug delivery apparatus
JP2005511582A (ja) *	2001-11-05	2005-04-28	ファルマシアアンドアップジョンカンパニーリミティドライアビリティーカンパニー	抗ムスカリン・エアゾール
BR0315258A (pt) *	2002-10-29	2005-08-23	Pharmacia & Upjohn Co Llc	Compostos de amÈnio quaternário
PL378583A1 (pl) *	2003-03-21	2006-05-02	Dynogen Pharmaceuticals, Inc.	Sposoby leczenia zaburzeń dolnych dróg układu moczowego z zastosowaniem modulatorów mięśni gładkich i modulatorów podjednostki Ó2Ű kanałów wapniowych
US6846823B2 (en) *	2003-04-04	2005-01-25	Dynogen Pharmaceuticals, Inc.	Method of treating lower urinary tract disorders
EP1817034A1 (en) *	2004-10-25	2007-08-15	Schering Corporation	M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders

2008
- 2008-05-30 KR KR20147034785A patent/KR20150011379A/ko not_active Ceased
- 2008-05-30 BR BRPI0812000-5A2A patent/BRPI0812000A2/pt not_active IP Right Cessation
- 2008-05-30 AU AU2008259864A patent/AU2008259864C1/en not_active Ceased
- 2008-05-30 CA CA2688542A patent/CA2688542C/en not_active Expired - Fee Related
- 2008-05-30 KR KR1020097025995A patent/KR20100021451A/ko not_active Ceased
- 2008-05-30 WO PCT/US2008/065436 patent/WO2008151092A1/en not_active Ceased
- 2008-05-30 US US12/130,903 patent/US20080299207A1/en not_active Abandoned
- 2008-05-30 EP EP08769938A patent/EP2152232A4/en not_active Withdrawn
- 2008-05-30 CA CA2859004A patent/CA2859004A1/en not_active Abandoned
2013
- 2013-11-14 AU AU2013257482A patent/AU2013257482B2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2013257482B2 (en)	2016-07-14
AU2008259864A1 (en)	2008-12-11
AU2008259864C1 (en)	2014-03-06
US20080299207A1 (en)	2008-12-04
EP2152232A1 (en)	2010-02-17
KR20150011379A (ko)	2015-01-30
KR20100021451A (ko)	2010-02-24
WO2008151092A1 (en)	2008-12-11
CA2688542A1 (en)	2008-12-11
AU2008259864B2 (en)	2013-08-22
EP2152232A4 (en)	2010-06-09
CA2688542C (en)	2016-07-12
CA2859004A1 (en)	2008-12-11

Publication	Publication Date	Title
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
BRPI0909780A2 (pt)	2015-08-11	Composições e métodos para liberação de fármaco
PT2144998T (pt)	2017-04-07	Métodos e composições para vírus vivos atenuados
BRPI0813725A2 (pt)	2014-12-30	Métodos e composições para tratamento de doenças
BRPI0819218A2 (pt)	2015-05-05	Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0918652A2 (pt)	2015-08-25	Composições farmacêuticas e métodos de libração relacionadas.
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0820980A2 (pt)	2015-06-23	Composições e métodos para detecção de tiabs
BRPI0919466A2 (pt)	2015-12-01	composição farmacêutica para liberação modificada
RU2493831C3 (ru)	2017-06-08	Фармацевтические композиции
BRPI0812562A2 (pt)	2019-09-24	composições terapêuticas anti-cd20 e métodos
DK2214679T3 (da)	2019-05-20	Kortikosteroidsammensætninger
EP2240022A4 (en)	2012-04-25	PHARMACEUTICAL COMPOSITIONS
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
BRPI0918971A2 (pt)	2015-12-01	tienopirimidinas para composições farmacêuticas
DK2068886T3 (da)	2013-11-18	Lipidholdige præparater
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
EP2373681A4 (en)	2013-11-06	PHARMACEUTICAL COMPOSITIONS
PT2868315T (pt)	2017-09-04	Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-03	B08F	Application fees: application dismissed [chapter 8.6 patent gazette]
2018-07-24	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2465 DE 03-04-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.